Comparison

CTX-712 European Partner

€9,347.00
Excl. VAT
Item no. HY-144875-100mg
Manufacturer MedChem Express
CASRN 2144751-78-8
Amount 100 mg
Category
Type Chemicals
Specific against other
Purity 98.60
Formula C19H17FN8O2
Citations [1]Fused heterocyclic compounds. Patent JPWO2017188374A1.
Smiles CC1=NC2=NC=C(C3=C4C(OC)=NC=NN4C=C3)C=C2N1CC5=NN=C([C@H](F)C)O5
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
CTX-712 is a potent inhibitor of cdc2-like kinase (CLK). CTX-712 inhibits CLK kinase activity, and thus inhibits cancer survival and cancer cell growth. CTX-712 has the potential for the research of cancer disease (extracted from patent JPWO2017188374A1, compound 286)[1].
StorageTemperature
4°C (Powder, sealed storage, away from moisture and light)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
Molecular Weight
408.39
Clinical Information
Phase 2
Solubility
DMSO : 25 mg/mL (ultrasonic)
Pathway
Cell Cycle/DNA Damage
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
Listprice: €9,347.00
Price: €9,347.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close